Please join us this Wednesday, January 31, 2018 at 4:00 p.m. PST for a live show with host Denise Messenger. Our special guest is Dr. David Steenblock. We will be discussing an ALS treatment he has pioneered. Dr. Steenblock earned his B.S. degree from Iowa State University, then an M.S. in biochemistry and Doctor of Osteopathy (D.O.) degree from the College of Osteopathic Medicine and Surgery in Des Moines, Iowa. He co-authored one of the very first lay-level books on umbilical cord stem cell therapy ever published titled “Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns” (Basic Health Publications). Beginning in 2005, Dr. Steenblock pioneered the harvesting and infusion of stem cell rich bone marrow aspirate concentrate (BMAC) along with FDA approved pharmaceutical stem cell activators to successfully treat a wide range of chronic medical conditions and diseases. In addition, in 2014-5 Dr. Steenblock carried out a retrospective study which revealed that 52 of 54 sporadic ALS patients he treated over a four year period (2011-2015) had a specific type of spine injury/reinjury which he has identified as a unique risk factor and biomarker for ALS. In late October 2015 Dr. Steenblock was awarded the Academy of Comprehensive Integrative Medicine's "Lifetime Achievement Award" at their NeuroRegeneration conference in Orlando, Florida.